Inventor · disambiguated record
Jeffrey Philip Poyser
Also filed as: POYSER JEFFREY P · POYSER JEFFREY PHILIP
11 granted patents·5 pending applications·49 citations·filing 1989–2013
87Inventor score
Top patents by PatentIndex Score
16 records- 0179US6806274B1Quinazoline derivativesASTRAZENECA UK LTD·Filed 2000·Granted Oct 19, 2004·15 cites·7 claims
- 0276US7001904B1Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseasesASTRAZENECA AB·Filed 2001·Granted Feb 21, 2006·9 cites·9 claims
- 0372US7906645B2Heterocyclic compounds as ccr2b antagonistsASTRAZENECA AB·Filed 2005·Granted Mar 15, 2011·1 cites·15 claims
- 0470US5126444AIntermediates for cephalosporin compoundsICI PLC·Filed 1991·Granted Jun 30, 1992·12 cites·1 claims
- 0566US7572826B2Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2ASTRAZENECA AB·Filed 2004·Granted Aug 11, 2009·2 cites·16 claims
- 0666US7553868B2Thiophene carboxamides as inhibitors of the enzyme IKK-2ASTRAZENECA AB·Filed 2004·Granted Jun 30, 2009·2 cites·12 claims
- 0765US5064824ACephalosporin compoundsICI PLC·Filed 1989·Granted Nov 12, 1991·8 cites·8 claims
- 0860US7956084B2Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2ASTRAZENECA AB·Filed 2006·Granted Jun 7, 2011·0 cites·2 claims
- 0960US2010029754A1Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1059US2009215829A1Thiophene carboxamides as inhibitors of the enzyme ikk-2MORLEY ANDREW DAVID·Filed 2009·Application pending·0 cites
- 1157US8710224B2Heterocyclic compounds as CCR2B antagonistsASTRAZENECA AB·Filed 2013·Granted Apr 29, 2014·0 cites·8 claims
- 1253US2012264762A1Heterocyclic Compounds as CCR2 AntagonistsBOWER JUSTIN FAIRFIELD·Filed 2012·Application pending·0 cites
- 1351US2011136820A1Heterocyclic Compounds as CCR2 AntagonistsASTRAZENECA AB·Filed 2011·Application pending·0 cites
- 1449US2011152234A1Novel CompoundsFAULL ALAN·Filed 2010·Application pending·0 cites
- 1542US7943768B2Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseasesASTRAZENECA AB·Filed 2006·Granted May 17, 2011·0 cites·10 claims
- 1639US7498335B2Method of producing an antiangiogenic or vascular permeability reducing effectASTRAZENECA AB·Filed 2001·Granted Mar 3, 2009·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →